Prolactin Acts on Myeloid Progenitors to Modulate SMAD7 Expression and Enhance Hematopoietic Stem Cell Differentiation into the NK Cell Lineage
Open Access
- 14 April 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-12
Abstract
Numerous cell types modulate hematopoiesis through soluble and membrane bound molecules. Whether developing hematopoietic progenitors of a particular lineage modulate the differentiation of other hematopoietic lineages is largely unknown. Here we aimed to investigate the influence of myeloid progenitors on CD34+ cell differentiation into CD56+ innate lymphocytes. Sorted CD34+ cells cultured in the presence of stem cell factor (SCF) and FMS-like tyrosine kinase 3 ligand (FLT3L) give rise to numerous cell types, including progenitors that expressed the prolactin receptor (PRLR). These CD34+PRLR+ myeloid-lineage progenitors were derived from granulocyte monocyte precursors (GMPs) and could develop into granulocytes in the presence of granulocyte-macrophage colony-stimulating factor (GM-CSF) in vitro. Moreover, CD34+PRLR+ myeloid progenitors lacked lymphoid developmental potential, but when stimulated with prolactin (PRL) they increased the differentiation of other CD34+ cell populations into the NK lineage in a non-contact dependent manner. Both mRNA and protein analyses show that PRL increased mothers against decapentaplegic homolog 7 (SMAD7) in CD34+PRLR+ myeloid cells, which reduced the production of transforming growth factor beta 1 (TGF-β1), a cytokine known to inhibit CD56+ cell development. Thus, we uncover an axis whereby CD34+PRLR+ GMPs inhibit CD56+ lineage development through TGF-β1 production and PRL stimulation leads to SMAD7 activation, repression of TGF-β1, resulting in CD56+ cell development.Keywords
Funding Information
- U.S. Department of Health & Human Services | National Institutes of Health (1R01AI100879)
- U.S. Department of Health & Human Services | National Institutes of Health
This publication has 74 references indexed in Scilit:
- Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported MethodsTransplantation and Cellular Therapy, 2012
- Membrane-bound human SCF/KL promotes in vivo human hematopoietic engraftment and myeloid differentiationBlood, 2012
- Development of IL-22–producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissueBlood, 2011
- Natural killer–cell differentiation by myeloid progenitorsBlood, 2011
- TGF‐β affects development and differentiation of human natural killer cell subsetsEuropean Journal of Immunology, 2010
- Nuocytes represent a new innate effector leukocyte that mediates type-2 immunityNature, 2010
- IL-7 and IL-15 independently program the differentiation of intestinal CD3−NKp46+ cell subsets from Id2-dependent precursorsJournal of Experimental Medicine, 2010
- Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell–derived lin–CD34+CD43+CD45+ progenitorsJournal of Clinical Investigation, 2009
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activityBlood, 2009
- Cytokines regulating hematopoietic stem cell functionCurrent Opinion in Hematology, 2008